Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(25%)

Phase Distribution

Ph phase_1
4
100%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(1)
Other(3)

Detailed Status

unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

unknown375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_1

Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals

NCT00218049
unknownphase_1

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

NCT00089687
unknownphase_1

Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

NCT00051896
unknownphase_1

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

NCT00100113

Clinical Trials (4)

Showing 4 of 4 trials
NCT00218049Phase 1

Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals

Terminated
NCT00089687Phase 1

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

Unknown
NCT00051896Phase 1

Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

Unknown
NCT00100113Phase 1

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4